Concepedia

Dana A. Kennedy

DA

Statistics

Publications

36

Citations

6.2K

H-Index

26

Active since

1971

Affiliations

Seagen (United States)(Current)

The University of Texas MD Anderson Cancer Center

Washington University in St. Louis

Stanford Medicine

Sylvester Comprehensive Cancer Center

Dana A. Kennedy is an author at Seagen (United States) specializing in medicine, oncology, and immunology.

Top concepts

Publications per year

1971–2025

36

Publications

36

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

Anas Younes, Ajay K. Gopal, Scott E. Smith et al. · Journal of Clinical Oncology · 2012 · 1.5K citations · Full text

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

Anas Younes, Nancy L. Bartlett, John P. Leonard et al. · New England Journal of Medicine · 2010 · 1.3K citations · Full text

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

Barbara Pro, Ranjana H. Advani, Pauline Brice et al. · Journal of Clinical Oncology · 2012 · 979 citations · Full text

Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin

Steven M. Horwitz, Ranjana H. Advani, Nancy L. Bartlett et al. · Blood · 2014 · 349 citations · Full text

Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression

Eric D. Jacobsen, Jeff P. Sharman, Yasuhiro Oki et al. · Blood · 2015 · 297 citations · Full text

1–5 of 36